Sulowicz J, Cieniawski D, Ignacak E, Betkowska-Prokop A, et al. Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose
and Hemoglobin Concentration in Transplant Patients Treated With Proliferation
Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus). Transplant Proc 2020 Apr 16. pii: S0041-1345(19)31799.
PMID: 32307148